Medtech Industry Trends

How medical device manufacturing can be brought back to the US

How medical device manufacturing can be brought back to the US

GE HealthCare leads in FDA AI-enabled medical device authorizations, showcasing innovation in imaging and diagnostics to enhance patient care and streamline workflows.

Bruin Biometrics CEO Martin Burns discusses the "formulas" that guided the company through the challenges of bringing a device to market.

In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.

In a wide-ranging interview, Martin Burns discusses Bruin Biometrics’ Provizio SEM Scanner, why diagnostic and prevention tech innovation is underfunded and the challenges and opportunities facing the MedTech industry.

Texas A&M and Humanate debut an emotionally intelligent AI assistant to ease clinic workloads. Its name is Cassie.

Having a DCES on staff helps, but virtual options are also effective

2,000 consumers offered their feedback on medical devices. Here are the findings.

GlobalData report says hospitals may be accelerating purchases of certain medical devices

Medtronic announces a diabetes business spinoff to enhance focus on growth areas, aiming for improved financial performance and shareholder value.

U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.

A new whitepaper by LeagueMed’s founders offers a practical roadmap for turning early-stage MedTech innovations into successful businesses.

The HELM Life Sciences Cluster created to accelerate global health care innovation

In head-to-head comparison, artificial intelligence gave more guidance-adherent and accurate recommendations than doctors in over 20% of cases.

Predictmedix cites growing role in health and safety for its device’s success

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

Report shows industry hitting the $1.3 trillion mark by 2029

Media report highlights how FDA workloads have increased, and delays for new technology approvals will likely suffer

People who requested genetic tests were customers, not patients, so legal protection may be limited.

AdvaMed, the Advanced Medical Technology Association, the trade group for medical device manufacturers, released a list of priorities for Congress. Here are some of the key objectives.

With the majority of devices manufactured outside the U.S., any increase in tariffs is likely to drive up health care costs